SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Q3 Trading Update

19 Oct 2017 07:00

RNS Number : 0140U
Rentokil Initial PLC
19 October 2017
Ā 

Ā 

RENTOKIL INITIAL PLC (RTO)

THIRD QUARTER TRADING UPDATE

19 October 2017

Ā 

Ā 

(Ā£m)

Ā 

Q3 2017

Growth

Ā 

Ā 

AER

AER

CER

Ongoing Revenue1

Ā 

579.5

17.7%

13.7%

Revenue

Ā 

603.3

4.3%

0.6%

Ā 

Ā 

Overview (CER)

Ā 

Ongoing Revenue increased by 13.7% in Q3, of which 3.7% was Organic Revenue2 growth (Q3 2016: 3.1%) and 10.0% was from acquisitions. Organic growth for the quarter excludes revenue from product sales by the Group to the Haniel JV. Organic growth including these revenues was 4.6% in the quarter.

Pest Control grew by 17.8% (5.6% Organic Revenue growth) with Growth markets delivering a 12.3% increase and Emerging markets delivering revenue growth of 65.7%, reflecting the impact of our joint venture in India. Our Hygiene operations continued to grow steadily, with revenues increasing by 13.2%, of which 2.6% was Organic Revenue growth. Ongoing Revenue in our Protect & Enhance markets declined by 0.2%, with an Organic Revenue decline of 1.7%, primarily due to ongoing market weakness in our UK property care business.

There have been continuing strong performances in Asia, Pacific, Latin America, and in our largest market, North America in Q3. Europe delivered a further improvement in Ongoing Revenue growth in the quarter, with revenues in France up 2.4% year on year.

A number of operations within our North American, Latin American and Rest of the World businesses were temporarily disrupted by severe weather conditions in September. Trading has now returned to normal in most of these markets, with the exception of Puerto Rico, which is expected to remain severely impacted for some time.

M&AĀ 

​We have acquired six businesses in Q3, five in Pest Control and one in Hygiene, with combined annualised revenues of Ā£4m in the 12 months prior to acquisition. Including deals completed in October, we have acquired a total of 34 businesses since January 2017, of which 26​ were in Pest Control and seven in Hygiene, primarily in Emerging and Growth markets. Combined annualised revenues of the businesses acquired totalled Ā£1​84m in the year prior to purchase. During the period we also completed on our transaction to divest eight laundries in France to RLD. Our pipeline of M&A opportunities going into Q4 and 2018 remains strong.

​Commenting on today's announcement Andy Ransom, Chief Executive, said:

"I am pleased with the ongoing progress we have made in the third quarter. Pest Control has delivered a further improvement in revenue growth at just under 18%, while our Hygiene business has maintained momentum, increasing revenues by over 13%. It has been a good period for M&A with six businesses acquired in Growth and Emerging markets, principally in Pest Control. We are also very pleased to have completed our divestment of eight flat linen laundries in France to RLD. Notwithstanding the impact of severe weather conditions on some of our businesses in the third quarter, prospects remain good for the remainder of the year across the majority of our markets, and our guidance for the full year is unchanged."

Enquiries:

Ā 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Ā 

Ā 

Ā 

Ā 

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

1Ongoing Revenue represents the performance of the continuing operations of the Group (including acquisitions) after removing the effect of disposed or closed businesses.

Ā 

2Organic Revenue represents the growth in Ongoing Revenue excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations.

Ā 

Ā 

Ā 

AER - actual exchange rates; CER - constant 2016 exchange rates

Ā 

This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
TSTDMMMGLRFGNZM
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.